Evidence map›Paper›PMID 26486793›Full record

ArticleMolecular imaging and biology2016

Magnetic Targeting and Delivery of Drug-Loaded SWCNTs Theranostic Nanoprobes to Lung Metastasis in Breast Cancer Animal Model: Noninvasive Monitoring Using Magnetic Resonance Imaging.

Achraf Al Faraj, Asma Sultana Shaik, Rabih Halwani, Abdulrahman Alfuraih

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Achraf Al FarajCollege of Applied Medical Sciences, Department of Radiological Sciences, Molecular and Cellular Imaging Lab, King Saud University, Riyadh, 11433, Saudi Arabia. aalfaraj@ksu.edu.sa.
Asma Sultana ShaikCollege of Medicine, Prince Naif Health Research Center, King Saud University, Riyadh, 11461, Saudi Arabia.
Rabih HalwaniCollege of Medicine, Prince Naif Health Research Center, King Saud University, Riyadh, 11461, Saudi Arabia.
Abdulrahman AlfuraihCollege of Applied Medical Sciences, Department of Radiological Sciences, Molecular and Cellular Imaging Lab, King Saud University, Riyadh, 11433, Saudi Arabia.
King Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn this study, we aimed to develop novel therapeutic and diagnostic approaches by improving the targeting of doxorubicin-loaded single-walled carbon nanotubes (SWCNTs) to metastatic regions, and monitor their preferential homing and enhanced therapeutic effect using noninvasive free-breathing magnetic resonance imaging (MRI) and bioluminescence imaging. PROCEDURES: High-energy flexible magnets were specifically positioned over the metastatic tumor sites in the lungs. SWCNTs biodistribution, tumor progression, and subsequent treatment efficiency were assessed following administration of the magnetically attracted doxorubicin-loaded anti-CD105 conjugated nanocarriers.

resultsThe use of high-energy magnets offered improved theranostic effect of doxorubicin-loaded nanocarriers, by magnetically targeting them towards metastatic tumor sites in the lungs. MRI allowed sensitive monitoring of nanocarriers biodistribution in the abdominal organs, their preferential homing towards the metastatic sites, and their enhanced therapeutic effect.

conclusionsCombination of noninvasive MRI to localize sensitively the tumor sites, with specific positioning of magnets that can enhance the magnetic targeting of nanocarriers, allowed increasing the treatment efficiency.

Indexed as

Drug Delivery SystemsAnimalsDisease Models, AnimalDoxorubicinFemaleLuminescent MeasurementsLung NeoplasmsMagnetic Resonance ImagingMammary Neoplasms, AnimalMiceNanotubes, CarbonTheranostic NanomedicineTissue DistributionTreatment OutcomeDoxorubicinNanotubes, CarbonCarbon nanotubesDiagnostic and therapeutic nanoprobesDrug delivery systemsDrug targetingLung imagingMagnetic resonance imagingMetastatic breast cancer

Identifiers

PMID26486793
OpenAlexW2117109632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.